Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes

SIMPLE SUMMARY: GD2 is an antigen that is tumor-specific and can be used as a target for specific immunotherapies. Since the knowledge about GD2 in breast cancer is limited, we analyzed the frequency of GD2 expression in breast cancer using two different staining methods and the impact of GD2 expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Erber, Ramona, Kailayangiri, Sareetha, Huebner, Hanna, Ruebner, Matthias, Hartmann, Arndt, Häberle, Lothar, Meyer, Julia, Völkl, Simon, Mackensen, Andreas, Landgraf, Laura, Geppert, Carol I., Schulz-Wendtland, Rüdiger, Beckmann, Matthias W., Fasching, Peter A., Farwick, Nicole, Rossig, Claudia, Gass, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582848/
https://www.ncbi.nlm.nih.gov/pubmed/34771738
http://dx.doi.org/10.3390/cancers13215577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582848/
https://www.ncbi.nlm.nih.gov/pubmed/34771738
http://dx.doi.org/10.3390/cancers13215577

Ejemplares similares